Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis after Fingolimod Withdrawal
Neurotherapeutics(2022)
Key words
Multiple sclerosis,Fingolimod,Natalizumab,Anti-CD20,Therapeutics,Effectiveness,Flexible model
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined